THE 5-HT3 RECEPTOR IN MAMMALIAN BRAIN - A NEW TARGET FOR THE DEVELOPMENT OF PSYCHOTROPIC-DRUGS

被引:19
作者
APUD, JA
机构
[1] Fidia-Georgetown Institute for the Neurosciences, Georgetown University Medical School, Washington, DC
[2] Fidia-Georgetown Institute for the Neurosciences, Georgetown University Medical School, Washington, DC, 20007
关键词
SEROTONIN; SEROTONIN RECEPTORS; 5-HT3 BINDING SITES; 5-HT3 RECEPTOR ANTAGONISTS; LIGAND-GATED NA+-K+ CHANNEL;
D O I
10.1038/npp.1993.13
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Serotonin (5-HT) is a neurotransmitter in the central nervous system (eNS) of vertebrates and invertebrates. In vertebrates, 5-HT participates in the regulation of various physiologic functions, including pain perception, blood pressure, sleep, homeothermia, and sexual activity. It is also believed that 5-HT may participate in the expression of symptoms of certain psychiatric disorders, such as depression and anxiety. In this context, most of our knowledge concerning the participation of S-HT and 5-HT receptors in psychopathology has come from the characterization of the mechanisms of action of various drugs that are effective in relieving the symptoms of psychiatric disorders. That the 5-HT receptor population in the periphery might be heterogeneous was fIrst suggested by the early pioneering work of two independent groups (Rocha e Silva et a1. 1953; Gaddum and Hameed 1954). It was not until the late 1970s, however, that Peroutka and Snyder (1979) described, in the eNS, the existence of two different 5-HT recognition sites labeled by lysergic acid diethylamine, the serotonin-1 (5-HT1) and the serotonin-2 (5-HT2) binding sites. © 1993 American College of Neuropsychopharmacology.
引用
收藏
页码:117 / 130
页数:14
相关论文
共 112 条
  • [1] THE PERMEABILITY OF ENDPLATE CHANNELS TO MONO-VALENT AND DIVALENT METAL-CATIONS
    ADAMS, DJ
    DWYER, TM
    HILLE, B
    [J]. JOURNAL OF GENERAL PHYSIOLOGY, 1980, 75 (05) : 493 - 510
  • [2] NEUROPHARMACOLOGY OF EMESIS INDUCED BY ANTI-CANCER THERAPY
    ANDREWS, PLR
    RAPEPORT, WG
    SANGER, GJ
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1988, 9 (09) : 334 - 341
  • [3] IDENTIFICATION AND CHARACTERIZATION OF 5-HYDROXYTRYPTAMINE3 RECOGNITION SITES IN HUMAN-BRAIN TISSUE
    BARNES, JM
    BARNES, NM
    COSTALL, B
    IRONSIDE, JW
    NAYLOR, RJ
    [J]. JOURNAL OF NEUROCHEMISTRY, 1989, 53 (06) : 1787 - 1793
  • [4] 5-HT3 RECEPTORS MEDIATE INHIBITION OF ACETYLCHOLINE-RELEASE IN CORTICAL TISSUE
    BARNES, JM
    BARNES, NM
    COSTALL, B
    NAYLOR, RJ
    TYERS, MB
    [J]. NATURE, 1989, 338 (6218) : 762 - 763
  • [5] CHARACTERIZATION AND AUTORADIOGRAPHIC LOCALIZATION OF 5-HT3 RECEPTOR RECOGNITION SITES IDENTIFIED WITH [3H]-(S)-ZACOPRIDE IN THE FOREBRAIN OF THE RAT
    BARNES, JM
    BARNES, NM
    CHAMPANERIA, S
    COSTALL, B
    NAYLOR, RJ
    [J]. NEUROPHARMACOLOGY, 1990, 29 (11) : 1037 - &
  • [6] BARNES JM, 1989, BRIT J PHARMACOL, V98, pP693
  • [7] [H-3] ZACOPRIDE - LIGAND FOR THE IDENTIFICATION OF 5-HT3 RECOGNITION SITES
    BARNES, NM
    COSTALL, B
    NAYLOR, RJ
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1988, 40 (08) : 548 - 551
  • [8] ACTIVATION OF A 5-HT3 RECEPTOR RELEASES DOPAMINE FROM RAT STRIATAL SLICE
    BLANDINA, P
    GOLDFARB, J
    GREEN, JP
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 155 (03) : 349 - 350
  • [9] BLANDINA P, 1989, J PHARMACOL EXP THER, V251, P803
  • [10] COMMON PHARMACOLOGICAL AND PHYSICOCHEMICAL PROPERTIES OF 5-HT3 BINDING-SITES IN THE RAT CEREBRAL-CORTEX AND NG 108-15 CLONAL CELLS
    BOLANOS, FJ
    SCHECHTER, LE
    MIQUEL, MC
    EMERIT, MB
    RUMIGNY, JF
    HAMON, M
    GOZLAN, H
    [J]. BIOCHEMICAL PHARMACOLOGY, 1990, 40 (07) : 1541 - 1550